Compounds > 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline
Page last updated: 2024-10-29

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Adenomatous Polyposis Coli

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline has been researched along with Adenomatous Polyposis Coli in 1 studies

WHI P131: a quinazoline derivative, inhibitor of glioblastoma cell adhesion and migration

Adenomatous Polyposis Coli: A polyposis syndrome due to an autosomal dominant mutation of the APC genes (GENES, APC) on CHROMOSOME 5. The syndrome is characterized by the development of hundreds of ADENOMATOUS POLYPS in the COLON and RECTUM of affected individuals by early adulthood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Uckun, FM1
Erbeck, D1
Qazi, S1
Venkatachalam, T1
Tibbles, HE1
Vassilev, A1

Other Studies

1 other study available for 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Adenomatous Polyposis Coli

ArticleYear
Effect of targeting janus kinase 3 on the development of intestinal tumors in the adenomatous polyposis coli(min) mouse model of familial adenomatous polyposis.
    Arzneimittel-Forschung, 2007, Volume: 57, Issue:6

    Topics: Adenomatous Polyposis Coli; Animals; beta Catenin; Chromatography, High Pressure Liquid; Enzyme Inhi

2007